Article info
Commentary
MEK inhibition for low-grade serous ovarian cancer: are we there yet?
- Correspondence to Dr Mariana Scaranti, Hospital Sírio-Libanês, Sao Paulo, SP 01308-050, Brazil; scarantimariana{at}gmail.com
Citation
MEK inhibition for low-grade serous ovarian cancer: are we there yet?
Publication history
- Received October 11, 2020
- Accepted October 26, 2020
- First published November 10, 2020.
Online issue publication
January 04, 2021
Article Versions
- Previous version (10 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.